Personal Cfo Solutions, LLC Vertex Pharmaceuticals Inc Transaction History

Personal Cfo Solutions, LLC

$704 Million
Q3 2024

A detailed history of Personal Cfo Solutions, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 687 shares of VRTX stock, worth $309,816. This represents 0.05% of its overall portfolio holdings.

Number of Shares

687

Previous 663 3.62%

Holding current value

$309,816

Previous $310,000 2.9%

% of portfolio

0.05%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $11,040 - $12,138	24 Added 3.62%	687 $319,000
Q2 2024 Aug 09, 2024	SELL	$392.81 - $485.53 $785 - $971	-2 Reduced 0.3%	663 $310,000
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $132,091 - $144,529	-324 Reduced 32.76%	665 $277,000
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $25,382 - $30,390	-74 Reduced 6.96%	989 $402,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $96,043 - $102,938	284 Added 36.46%	1,063 $369,000
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $21,694 - $24,281	-69 Reduced 8.14%	779 $274,000
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $28,889 - $32,956	-102 Reduced 10.74%	848 $267,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $571 - $642	2 Added 0.21%	950 $274,000
Q3 2022 Nov 01, 2022	BUY	$273.83 - $305.53 $821 - $916	3 Added 0.32%	948 $274,000
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $188,202 - $234,332	-801 Reduced 45.88%	945 $266,000
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $182,007 - $214,517	822 Added 88.96%	1,746 $456,000
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $163,557 - $206,467	924 New	924 $203,000
Q2 2021 Jul 22, 2021	SELL	$187.49 - $221.1 $251,611 - $296,716	-1,342 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$207.02 - $241.31 $93,780 - $109,313	453 Added 50.96%	1,342 $288,000
Q4 2020 Feb 09, 2021	BUY	$207.01 - $276.09 $1,449 - $1,932	7 Added 0.79%	889 $210,000
Q3 2020 Nov 02, 2020	BUY	$255.65 - $303.1 $38,091 - $45,161	149 Added 20.33%	882 $0
Q2 2020 Aug 03, 2020	BUY	$225.48 - $295.8 $165,276 - $216,821	733 New	733 $213,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account

Personal Cfo Solutions, LLC Vertex Pharmaceuticals Inc Transaction History